Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6963)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2018 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen YC, Li CY, Tsai SJ, Chen YC. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection. World J Gastroenterol 2018; 24(8): 917-928 [PMID: 29491685 DOI: 10.3748/wjg.v24.i8.917] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i8/917.htm |
| Number | Citing Articles |
| 1 |
Chien-Hsueh Tung, Ning-Sheng Lai, Chung-Yi Li, Shiang-Jiun Tsai, Yen-Chun Chen, Yi-Chun Chen. Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database. BMJ Open 2018; 8(7): e021747 doi: 10.1136/bmjopen-2018-021747
|
| 2 |
Fabrizio Fabrizi, Roberta Cerutti, Ezequiel Ridruejo. Hepatitis B virus infection as a risk factor for chronic kidney disease. Expert Review of Clinical Pharmacology 2019; 12(9): 867 doi: 10.1080/17512433.2019.1657828
|
| 3 |
F. Fabrizi, R. Cerutti, F.M. Donato, P. Messa. La infección por VHB es un factor de riesgo de enfermedad renal crónica: revisión sistemática y metaanálisis. Revista Clínica Española 2021; 221(10): 600 doi: 10.1016/j.rce.2019.10.010
|
| 4 |
Joel Neugarten, Ladan Golestaneh. Chronic Renal Disease. 2020; : 863 doi: 10.1016/B978-0-12-815876-0.00053-X
|
| 5 |
Jayoun Lee, Songhee Cho, Hyo Jeong Kim, Hangil Lee, Min Jung Ko, Young‐Suk Lim. High level of medication adherence is required to lower mortality in patients with chronic hepatitis B taking entecavir: A nationwide cohort study. Journal of Viral Hepatitis 2021; 28(2): 353 doi: 10.1111/jvh.13418
|
| 6 |
Kevin Lu, Kun-Yuan Chiu. Lifetime Risk of Hepatorenal Events Assessed in Longitudinal Cohort of Renal Transplant Recipients with HBV Infection. Transplantation Proceedings 2023; 55(7): 1581 doi: 10.1016/j.transproceed.2023.05.017
|
| 7 |
Mei-zhu Gao, Lin-lin Xu, Yang Li, Xin Wang, Pei Chen, Su-fang Shi, Li-jun Liu, Ji-cheng Lv, Fu-Yuan Hong, Hong Zhang, Xu-jie Zhou. Hepatitis B Virus Status and Clinical Outcomes in IgA Nephropathy. Kidney International Reports 2024; 9(4): 1057 doi: 10.1016/j.ekir.2024.01.009
|
| 8 |
Danjing Chen, Rong Yu, Shuo Yin, Wenxin Qiu, Jiangwang Fang, Xian-e Peng. Hepatitis B virus infection as a risk factor for chronic kidney disease: a systematic review and meta-analysis. BMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-024-09546-z
|
| 9 |
Yi-Chun Chen, Chung-Yi Li, Shiang-Jiun Tsai, Yen-Chun Chen. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals. World Journal of Clinical Cases 2019; 7(11): 1270-1281 doi: 10.12998/wjcc.v7.i11.1270
|
| 10 |
Chien‐Hsueh Tung, Chung‐Yi Li, Yen‐Chun Chen, Yi‐Chun Chen. Association between nucleos(t)ide analogue therapy for hepatitis B and Sjögren’s syndrome: 15‐year analysis of the national database of Taiwan. Journal of Viral Hepatitis 2021; 28(5): 809 doi: 10.1111/jvh.13481
|
| 11 |
Yi-Chun Chen, Shiang-Jiun Tsai, Jin-Cherng Chen, Juen-Haur Hwang, Vinaya Manchaiah. Risks of tinnitus, sensorineural hearing impairment, and sudden deafness in patients with non-migraine headache. PLOS ONE 2019; 14(9): e0222041 doi: 10.1371/journal.pone.0222041
|
| 12 |
F. Fabrizi, R. Cerutti, F.M. Donato, P. Messa. HBV infection is a risk factor for chronic kidney disease: Systematic review and meta-analysis. Revista Clínica Española (English Edition) 2021; 221(10): 600 doi: 10.1016/j.rceng.2019.10.014
|